Lab members are in bold,   * Co-first authors,   Co-corresponding authors

  • Donaldson-Collier M.C.*, Sungalee S.*, Zufferey M.*, Tavernari D.*, Katanayeva N., Battistello E., Mina M., Douglass K., Rey T., Raynaud F., Manley S.,
    Ciriello G., Oricchio E. (2019) EZH2 oncogenic mutations drive epigenetic, transcriptional, and structural changes within topologically associating domains.
    Nat. Genetics,

    Check out the Video Abstract:

    • "The 3D Genome: EZH2 Comes into the Fold" Gerard L. Brien & Adrian P. Bracken, Trends in Molecular Medicine
    • Elisa's Interview at the Radio Television Suisse (French)
    • Also highlighted in:

  • Zufferey M.*, Tavernari D.*, Oricchio E., Ciriello G. (2018) Comparison of computational methods for the identification of topologically associating domains. Genome Biology, 19:217

  • Saghafinia S.*, Mina M.*, Riggi N., Hanahan D., Ciriello G. (2018) Pan-cancer landscape of aberrant DNA methylation across human tumors . Cell Reports, 25(4), 1066-1080

  • Raynaud F., Mina M., Tavernari D., Ciriello G. (2018) Pan-cancer inference of intra-tumor heterogeneity reveals associations with different forms of genomic instability . PLoS Genetics, 14(9), e1007669.

  • Sanchez-Vega F.*, Mina M.*, Armenia J.*, Chatila W.K., Luna A., La K.C., Dimitriadoy S., Liu D.L., Kantheti H.S., Saghafinia S., Chakravarty D., Daian F., Gao Q., Bailey M.H., Liang W., Foltz S.M., Shmulevich I., Ding I., Heins Z., Ochoa A., Gross B., Gao J., Zhang H., Kundra R., Kandoth C., Bahceci I., Dervishi L., Dogrusoz U., Zhou W., Shen H., Laird P.W., Way G.P., Greene C.S., Liang H., Xiao Y., Wang C., Iavarone A., Berger A.H., Bivona T.G., Lazar A.J., Hammer G.D., Giordano T., Kwong L.N., McArthur G., Huang C., Tward A.D., Frederick M.J., McCormick F., Meyerson M., The Cancer Genome Atlas Research Network, Van Allen E.M., Cherniack A.D.,
    Ciriello G., Sander C., Schultz N. (2018) Oncogenic Signaling Pathways in The Cancer Genome Atlas . Cell, 173(2), 321-337

  • Battistello E., Katanayeva N., Dheilly E., Tavernari D., Donaldson M.C., Bonsignore L., Thome-Miazza M., Christie A.L., Murakami M.A., Michielin O., Ciriello G., Zoete V., Oricchio E. (2018) Pan-SRC kinase inhibition blocks B-cell receptor oncogenic signaling in non-Hodgkin lymphoma . Blood, 131(21), 2345-2356

    • "The future of kinase inhibitors for DLBCL?"   Sarah E. M. Herman Blood

  • Mina M., Raynaud F., Tavernari D., Battistello E., Sungalee S. , Saghafinia S., Laessle T., Sanchez-Vega F., Schultz N., Oricchio E., Ciriello G. (2017) Conditional Selection of Genomic Alterations Dictates Cancer Evolution and Oncogenic Dependencies. Cancer Cell, 32(2), 155-168

    • "Cliques and Schisms of Cancer Genes"   Peter J. Campbell. Cancer Cell
    • "Conditional selection determines the pathways of cancer evolution"   David Killock.
      Nature Review Clinical Oncology

  • Oricchio E., Katanayeva N., Donaldson M.C., Sungalee S., Pasion J.P., B├ęguelin W., Battistello E., Sanghvi V.R., Jiang M., Jiang Y., Teater M., Parmigiani A., Budanov A.V., Chan F.C., Shah S.P., Kridel R., Melnick A.M., Ciriello G. and Wendel H-G. (2017) Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma, Science Trans. Med., 9, 396

  • Ciriello G.*, Gatza M.L.*, Bexk A.H., Wilkerson M.D., Rhie S.K., Pastore A., Zhang H., McLellan M., Yau C., Kandoth C., Bowlby R., Shen H., Hayat S., Fieldhouse R., Lester S.C., Tse G.M.K., Factor R.E., Collins L.C., Allison K.H., Chen Y.Y., Jensen K., Johnson N.B., Oesterreich S., Mills G.B., Cherniack A., Robertson G., Benz C., Sander, C., Laird P.W., Hoadley K.A., King T.A., TCGA Research Network, Perou C.M., (2015) Comprehensive molecular portraits of invasive lobular breast cancer, Cell, 163, 2 506-519

  • Oricchio E., Ciriello G., Jiang M., Boyce M.H., Schatz. J.H., Heguy A., Viale A., de Stanchina E., Teruya-Feldstein J., Bouska A., McKeithan T., Sander C., Tam W., Seshan V.E., Chan J., Chaganti R.S.K & Wendel H.G. (2014) Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy. J. Exp. Medicine, 211, 7, 1379-91

  • Ciriello G., Miller L.M., Aksoy B.A., Senbabaoglu Y., Schultz N. & Sander C. (2013) Emerging landscape of oncogenic signatures across human cancers. Nat. Genetics, 45, 10, 1127-1133

  • Supplemental Data
    Access the recommendation on F1000Prime
    This article has been also highlighted in: EurekaAlert Economist HuffingtonPost ScienceDaily

  • Ciriello G., Sinha R., Hoadley K.A., Jacobsen A.S., Reva B., Perou C.M., Sander C. & Schultz N. (2013), The molecular diversity of Luminal A breast tumors. Breast Cancer Res. Treat., 141, 3, 409-420

  • Ciriello G., Cerami E.G., Sander C. & Schultz N. (2012), Mutual Exclusivity Analysis Identifies Oncogenic Network Modules. Genome Res., 22, 398-406

  • Access the recommendation on F1000Prime

  • The complete list of publications can be found here

Copyright © ciriellolab 2016